CCK-B RECEPTOR GENE VARIANT IS NOT ASSOCIATED WITH INCREASED RISK, NOR WITH DECREASED SURVIVAL IN PANCREATIC ADENOCARCINOMA

(1) First Department Of Medicine, University Of Szeged, Szeged, Hungary

(2) Department Of Molecular And Cell Biology, Boston University, Boston, United States

(3) First Department Of Medicine, University Of Szeged, Szeged, Hungary;2nd Department Of Pediatrics, University Children's Hospital, Comenius University Medical School, Bratislava, Slovakia

(4) First Deoartment Of Medicine, University Of Szeged, Szeged, Hungary

(5) Fejér Megyei Szent György Hospital, Szekesfehervar, Hungary

(6) Bács-Kiskun County Municipality Hospital, Kecskemet, Hungary

(7) Department Of Surgery, University Of Pecs, Pecs, Hungary

(8) Department Of Surgery, University Of Debrecen, Debrecen, Hungary

(9) Department Of Surgery, University Of Debrecen, Debrecen, Hungary

(10) Dr. Bugyi István Hospital, Szentes, Hungary

(11) National Institute Of Oncology, Budapest, Hungary

(12) Pándy Kálmán County Hopsital, Gyula, Hungary

(13) Department Of Surgery, University Of Szeged, Szeged, Hungary

(14) Department Of Molecular And Cell Biology, Boston University, Boston, United States



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)